Abbott US diabetes device sales up 27% amid largely positive Q1
Abbott has posted strong revenue for its diabetes devices in Q1, despite overall sales for the company narrowly missing Wall …
Post
-
-
LUMA Vision nets FDA clearance for 4D imaging catheter
The US Food and Drug Administration (FDA) has cleared LUMA Vision’s Verafeye catheter-based imaging system. Verafeye is a four-dimensional (4D), ultrasound-based …
-
Health Canada approves NanoSpeed’s test for vitamin D detection
Health Canada has granted approval for NanoSpeed Diagnostics’ Test4D Serum, designed to identify vitamin D levels in blood serum. This development …
-
FDA clears eGenesis’ genetically engineered porcine liver for Phase I trial
eGenesis has gained US Food and Drug Administration (FDA) clearance on an investigational new drug (IND) application for a genetically …
-
APAC coronary stent market set to grow at 3.2% CAGR through 2034
The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery disease (CAD) …
-
FDA authorises ActiveProtective’s belt for fall-related hip injuries
The US Food and Drug Administration (FDA) has granted marketing authorisation for ActiveProtective Technologies’ (APT) Tango Belt, a prescription-only wearable …
-
Cadwell invests in Australian company Seer Medical
Cadwell Industries has made a strategic investment in Australia-based Seer Medical, which specialises in home-based epilepsy diagnostics. The investment, made in …
-
FDA conditionally approves second cohort of Carmat’s artificial heart study
French company Carmat has secured conditional approval from the US Food and Drug Administration (FDA) to initiate the second cohort …
-
NEC Laboratories and Data-Driven.AI partner to advance medical diagnoses
NEC Laboratories Europe and Data-Driven.AI are collaborating to advance medical diagnoses with the use of AI and machine learning (ML). The …
-
Satio and Nanowear to advance at-home diagnostic and therapeutic care
Satio and Nanowear have entered a partnership agreement aimed at progressing home-based diagnostic and therapeutic care that is said to …
-
Nexalin secures patent on brain stimulation method for substance use disorders
Nexalin has received patent approval from the United States Patent and Trademark Office (USPTO) for its deep intracranial frequency stimulation …
-
FDA approves sale of Bruno Vision’s contact lenses with FusionTechnology
The US Food and Drug Administration (FDA) has approved the sale of Bruno Vision Care’s Deseyne contact lenses, which incorporate …
-
UK’s Birmingham University secures $300,000 to develop myeloma test
The University of Birmingham in the UK has secured £230,00 ($303,000) in funding from Cancer Research Horizons towards the development …
-
Edwards secures CE mark for transfemoral mitral valve implant
Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up market rivalry with Abbott. Edwards’ …
-
Inbiome’s bacterial identification system secures IVDR certification
Dutch diagnostics company Inbiome has secured the EU's In Vitro Diagnostic Regulation (IVDR) certification for its rapid bacterial identification system. This …
